702 related articles for article (PubMed ID: 17716735)
1. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Parisi V; Tedeschi M; Gallinaro G; Varano M; Saviano S; Piermarocchi S;
Ophthalmology; 2008 Feb; 115(2):324-333.e2. PubMed ID: 17716735
[TBL] [Abstract][Full Text] [Related]
2. Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration.
Parisi V; Perillo L; Tedeschi M; Scassa C; Gallinaro G; Capaldo N; Varano M
Retina; 2007 Sep; 27(7):879-90. PubMed ID: 17891012
[TBL] [Abstract][Full Text] [Related]
3. Macular function in eyes with open-angle glaucoma evaluated by multifocal electroretinogram.
Parisi V; Ziccardi L; Centofanti M; Tanga L; Gallinaro G; Falsini B; Bucci MG
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6973-80. PubMed ID: 22969069
[TBL] [Abstract][Full Text] [Related]
4. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
5. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.
Piermarocchi S; Saviano S; Parisi V; Tedeschi M; Panozzo G; Scarpa G; Boschi G; Lo Giudice G;
Eur J Ophthalmol; 2012; 22(2):216-25. PubMed ID: 22009916
[TBL] [Abstract][Full Text] [Related]
6. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Ma L; Dou HL; Huang YM; Lu XR; Xu XR; Qian F; Zou ZY; Pang HL; Dong PC; Xiao X; Wang X; Sun TT; Lin XM
Am J Ophthalmol; 2012 Oct; 154(4):625-634.e1. PubMed ID: 22835510
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
8. Effects of Macuprev
Parravano M; Tedeschi M; Manca D; Costanzo E; Di Renzo A; Giorno P; Barbano L; Ziccardi L; Varano M; Parisi V
Adv Ther; 2019 Sep; 36(9):2493-2505. PubMed ID: 31243641
[TBL] [Abstract][Full Text] [Related]
9. Carotenoids and co-antioxidants in age-related maculopathy: design and methods.
Neelam K; Hogg RE; Stevenson MR; Johnston E; Anderson R; Beatty S; Chakravarthy U
Ophthalmic Epidemiol; 2008; 15(6):389-401. PubMed ID: 19065432
[TBL] [Abstract][Full Text] [Related]
10. Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in early age-related macular degeneration.
Gin TJ; Luu CD; Guymer RH
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9267-74. PubMed ID: 22039238
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration.
Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S
Retina; 2009; 29(10):1450-6. PubMed ID: 19816240
[TBL] [Abstract][Full Text] [Related]
12. Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter.
Lai Y; Grattan J; Shi Y; Young G; Muldrew A; Chakravarthy U
Retina; 2011 Sep; 31(8):1620-6. PubMed ID: 21610564
[TBL] [Abstract][Full Text] [Related]
13. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
14. The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial.
Berrow EJ; Bartlett HE; Eperjesi F; Gibson JM
Br J Nutr; 2013 Jun; 109(11):2008-14. PubMed ID: 23084077
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography and multifocal electroretinography of patients with advanced neovascular age-related macular degeneration before, during, and after treatment with ranibizumab.
Almeida IN; Almeida LN; Almeida Sobrinho EF; Gomes BD; Souza Gda S; Rosa AA; Silveira LC
Arq Bras Oftalmol; 2015; 78(2):105-9. PubMed ID: 25945532
[TBL] [Abstract][Full Text] [Related]
16. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration.
Sandberg MA; Weiner A; Miller S; Gaudio AR
Ophthalmology; 1998 Mar; 105(3):441-7. PubMed ID: 9499774
[TBL] [Abstract][Full Text] [Related]
17. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
Retina; 2009; 29(7):960-5. PubMed ID: 19491727
[TBL] [Abstract][Full Text] [Related]
18. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.
Imai H; Honda S; Nakanishi Y; Yamamoto H; Tsukahara Y; Negi A
Br J Ophthalmol; 2006 Dec; 90(12):1524-30. PubMed ID: 16825279
[TBL] [Abstract][Full Text] [Related]
19. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
20. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
